INTERNATIONAL PATENT: SHANGHAI ESCUGEN BIOTECHNOLOGY CO., LTD., FORESEEN TECHNOLOGY (BEIJING) CO., LTD. FILES APPLICATION FOR "AN ANTI_ITGA2 ANTIBODY DRUG CONJUGATE"

GENEVA, July 28 -- SHANGHAI ESCUGEN BIOTECHNOLOGY CO., LTD. (5th Floor, Building 19, 2777 East Jinxiu RoadPudong New Area, Shanghai 201206), FORESEEN TECHNOLOGY (BEIJING) CO., LTD. (Floor 3, Building 9, No. 9 North Yongteng RoadHaidian District, Beijing 100094) filed a patent application (PCT/CN2025/072984) for "AN ANTI_ITGA2 ANTIBODY DRUG CONJUGATE" on Jan 17, 2025. With publication no. WO/2025/153055, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WONG, Catherine C. (Floor 3, Building 9, No. 9 North Yongteng RoadHaidia...